Incident and Prevalent Cases of Breast Cancer Continue to Grow as Effective Screening Boosts Survival Rates

The total number of breast cancer incident cases in the nine major markets (9MM) — the US, France, Germany, Italy, Spain, UK, Japan, urban China and Brazil — is expected to increase by 44% over the next decade, from 0.90 million in 2012 to 1.29 million by 2022.

The latest report states that the number of five-year prevalent cases will also grow by 44%, climbing from 3.7 million in 2012 to 5.39 million by 2022. Out of the 9MM, the US and urban China had the highest number of five-year prevalent cases in 2012, with 1.15 million and 898,406 cases, respectively.

Samantha Lee, Epidemiologist, says: “The forecast growth in breast cancer incidence is partly due to rising cases of obesity, growing detection through screening programs, and changes in reproductive patterns and the use of postmenopausal hormone replacement therapy.”

According to the World Health Organization, increased breast cancer survival has contributed greatly to the prevalence of the disease, and there is a large amount of evidence showing that breast cancer mammographic screening is effective in reducing the disease mortality by at least 20% in women aged 50 years and older.

Lee says: “Prevention measures taken to improve breast cancer survival in parts of the world where organized nationwide mammography screening has only been made available in recent years, such as Brazil and China, will boost survival rates and impact the disease incidence and prevalence in those countries.”

Nonetheless, epidemiologists expect the impact of screening in these markets to be limited in the short term. This is due to the lack of sufficient resources and infrastructure needed to support the downstream healthcare needs associated with screening, such as additional diagnostic tests and treatment.

Inquire about this report: http://www.marketresearchreports.com/globaldata/epicast-report-breast-cancer-epidemiology-forecast-2022

Find all Healthcare report at: http://www.marketresearchreports.com/healthcare

The global knee replacement market to reach $7,459 million in 2019, finds new report

The knee replacement market value across 10 major countries will undergo a slight increase over the next few years, from $6,544m in 2012 to $7,459m in 2019, at a Compound Annual Growth Rate (CAGR) of 1.9%.

The latest report states that out of the 10 major markets (10MM) – the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India – the US possessed the largest market share of 63% in 2012. This is expected to drop slightly to just below 61% in 2019.

According to analyst of this report “The knee replacement market represents the largest joint reconstruction market in the world. Although it has continued to grow at a steady rate in procedure volume, profit margins have been negatively affected by health executives scrutinizing purchases and using multiple channels to procure orthopedic devices at highly competitive prices.”

Nevertheless, the rising prevalence of symptomatic arthritis will drive the expected growth over the forecast period. Emerging markets, such as India and China, will see a higher growth level in knee replacement and will provide the key for players to gain additional market share.

Furthermore, technological advancements in joint reconstruction surgeries, such as computer-assisted systems, will also provide a boost to the market.

Analyst added: “As the knee replacement procedure volume rises over the next decade, it will become increasingly important to improve surgical accuracy and reduce revision rates to a specific level. Future competition among vendors will thus be more likely to center on the instrumentation and ancillary equipment, such as patient-specific instruments (PSIs), navigation systems, and robotic systems.”

However, a number of significant barriers will prevent a more impressive level of growth in the knee replacement market, including the deferral of procedures.

The analyst continues: “Current economic conditions are forcing patients to reconsider hip and knee replacements due to the costs involved and potential missed work days. Knee replacement is more likely to be deferred by patients in comparison with hip replacement, because medical treatments such as viscosupplementation can ease the pain.

“Additionally, cost-containment pressures are persisting in the US and EU healthcare systems, with a particular focus on limiting the spending on high-volume surgeries, such as knee replacement.”

For more information visit : http://www.marketresearchreports.com/globaldata/medipoint-knee-replacement-global-analysis-and-market-forecasts

Check our year end discount offers: http://www.marketresearchreports.com/special-offers

For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to-newsletter

The global cardiac rhythm management (CRM) market to cross $15.7 billion by 2020, finds new report

The global cardiac rhythm management (CRM) market is set to experience significant expansion and emerging market adoption, with revenues climbing from $10.9 billion in 2012 to more than $15.7 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 4.6%.

The latest report states that the US held the largest CRM market share in 2012, with 55%, and will continue to do so in 2020 – despite the potential slowing effect of Obamacare on revenue growth – with 45%. The 5EU countries – France, Germany, Italy, Spain and the UK – followed in 2012, with a share of 29%, which is due to rise to 32% by the end of the forecast period.

The anticipated expansion of the global CRM market will result from increasing incidences of arrhythmia and heart failure in the global population, combined with the growing market penetration of pacing and pulse generator technology in the Asia-Pacific and South American regions.

The lead analyst of this report says: “The extremely competitive CRM market is dominated by several key players, who must continue to innovate in the face of mounting pricing pressures and strict regulation as they battle to gain market share.

“New technologies currently under development, such as leadless pacemakers and energy harvesting generators, promise to heighten product sales and boost new account openings, while industry standards continue to develop in regards to remote home monitoring and rate-adaptive therapy.”

However, the CRM market will experience some barriers to further revenue growth during the forecast period. These include the high costs surrounding new CRM devices, along with a subsequent lack of reimbursement, which is also expected to limit hospital product offerings.

“Additionally, healthcare reforms introduced by the US government in 2010, namely the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act, may adversely affect the US medical devices market by increasing pressure on device manufacturers. This could therefore slow CRM growth in what continues to be the world’s largest market shareholder,” Littlefield concludes.

This report provides analysis on the cardiac rhythm management market in 10 major countries (10MM) – the US, France, Germany, Italy, Spain, the UK, Japan, China, India and Brazil.

For more information visit : http://www.marketresearchreports.com/globaldata/medipoint-cardiac-rhythm-management-global-analysis-and-market-forecasts

Check our year end discount offers: http://www.marketresearchreports.com/special-offers

For regular industry updates subscribe to our newsletter at:  http://www.marketresearchreports.com/subscribe-to-newsletter

U.S. Market for Dental Lasers, New Report Launched

In 2013, the total U.S. market for dental laser systems was valued at $72.5 million. This market will beprimarily driven by the soft tissue diode laser market segment.

The dental laser device market is divided into three main segments. First is the soft tissue dental laser market, which includes diode laser systems, CO2 laser systems and Nd:YAG laser systems. Second is the all tissue dental laser market, which includes Er:YAG laser systems and Er,Cr:YSGG laser systems. Last is the dental welding laser market, which includes both benchtop and standalone dental cameras. Positive growth will be exhibited by all segments over the forecast period; however, overall market growth will be driven primarily by growth of the soft tissue laser segment as a result of the increasing market penetration of diode lasers.

Scope: This report pertains to a forecast period of 10 years (2010 – 2020) for the U.S.

Report Contents:

• Competitor Analysis
• Identified Strategic Opportunities
• Market Overview by Segment
• Trend Analysis by Segment
• Market Drivers & Limiters
• Mergers & Acquisitions
• Customer Feedback and Market Monitoring

Main Segments Included:

• Soft Tissue Dental  Laser Market
• All Tissue Dental  Laser Market
• Dental Welding Laser Market

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.

Spanning over 128 pages, “U.S. Market for Dental Lasers” report provides information on Research Methodology, U.S. Dental Laser Market Overview, Soft Tissue Dental Laser Market, All Tissue Dental Laser Market, Dental Welding Laser Market, Abbreviations. In This report cover 32 Companies- LNA Laser, Z-Tech Advanced Technologies, LightScalpel, Biolase, Lutronic, Sirona, AMD Lasers, Millennium Dental Technologies, Ivoclar Vivadent, Zila, Fotona, DEKA Laser etc.

For more information visit : http://www.marketresearchreports.com/idata-research/us-market-dental-lasers

Find all Medical Devices Reports under a single page.

High demand in U.S. video, high-tech and integrated operating room devices market, finds new report

In 2013, the U.S. market for video, high-tech and integrated OR equipment exceeded $1.8 billion.

The video, high-tech and integrated operating room equipment market includes integrated OR components, camera systems, image capture devices, displays, PACS monitors, light sources, medical printers, headlights, lighting, booms, tables, insufflation devices and surgical microscopes. High demand for OR integration will be the primary driver for all markets directly correlated, such as surgical monitors, image capture and recording devices, PACS monitors and surgical cameras.

Scope: This report pertains to a forecast period of 10 years (2010– 2020) for the U.S.

Report Contents:

• Competitor Analysis
• Identified Strategic Opportunities
• Market Overview by Segment
• Trend Analysis by Segment
• Market Drivers & Limiters
• Mergers & Acquisitions
• Customer Feedback and Market Monitoring

Main Segments Included:

• Integrated Operating Room (OR) Market
• Surgical Camera System Market
• Image Capture and Recording Device Market
• Surgical Display and PACs Monitor Market
• Medical Printer Market
• Surgical Light Source Market
• Surgical Headlight Market
• Surgical Lighting Market
• Surgical Boom Market
• Surgical Table Market
• Insufflation Device Market
• Surgical Microscope Market

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.

Spanning over 294 pages, “U.S. Video, High-Tech and Integrated Operating Room Market” report provides information on Research Methodology, U.S. Video, High-Tech And Integrated Or Equipment Market, Integrated Operating Room Market, Surgical Camera System Market, Digital Image Capture And Recording Device Market, Surgical Display And Pacs Monitor Markets, Medical Printer Market, Surgical Light Source Market, Surgical Headlight Market, Surgical Lighting Market, Surgical Boom Market, Surgery Table Market, Surgical Microscope Market, Insufflation Device Market, Abbreviations. In This report cover 62 Companies. SONY Medical, Olympus, MAQUET, Skytron, Berchtold, NDS Surgical Imaging, Leica Microsystems, Arthrex, Orthopedic Systems Inc, Integra Lifesciences, ConMed, Barco, Smith & Nephew, Sunoptic Technologies, Stryker, Karl Storz, STERIS, Carl Zeiss, Allen Medical Systems, Baxter Healthcare etc.

For more information visit : http://www.marketresearchreports.com/idata-research/us-video-high-tech-and-integrated-operating-room-market

Find all Pharma and Healthcare under a single page.

By 2020, the U.S. market for peripheral vascular devices will be worth over $6 billion

The peripheral vascular device market includes stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, chronic total occlusion devices, stent grafts, surgical grafts, arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, catheters, guidewires, introducer sheaths, vascular closure devices and transcatheter embolization devices. These devices can be used for treating either coronary arterial or peripheral arterial disease (PAD), but only those devices used for peripheral procedures are included in this report. Older individuals and those who are obese have a higher risk of developing PAD. As result of a general increase in peripheral procedures and the development of new lower-limb treatments, the market for products such as stents and stent grafts will grow rapidly in the U.S. over the forecast period.

Peripheral artery disease (PAD) remains a significantly under treated condition in the U.S and PAD is the leading cause of leg amputation. These factors will continue to drive growth in the peripheral vascular device market. In particular, the peripheral stent market is projected to grow over the forecast period. However, intense competition has led to price erosion and market penetration has moderated this once high growth segment. The launch of new technologies, including drug-eluting stents, will generate marginal revenues and only one company has sought FDA approval. In contrast, significant investments and acquisitions have taken place in the efforts of bringing the first drug-eluting balloon to the market, with Medtronic and C. R. Bard in a tight race to gain approval.

Scope: This report pertains to a forecast period of 10 years (2010 – 2020) for the U.S.

Report Contents:

• Competitor Analysis
• Identified Strategic Opportunities
• Market Overview by Segment
• Trend Analysis by Segment
• Market Drivers & Limiters
• Mergers & Acquisitions
• Customer Feedback and Market Monitoring

Main Segments Included:

• Peripheral Vascular Stent Market
• PTA Balloon Catheter Market
• Atherectomy Device Market
• Chronic Total Occlusion (CTO) Device Market
• Embolic Protection Device Market
• Stent Graft Market
• Surgical Graft Market
• AV Access Thrombectomy Device Market
• Inferior Vena Cava Filter Market
• Diagnostic and Interventional Catheter Market
• Diagnostic and Interventional Guidewire Market
• Introducer Sheath Market
• Vascular Closure Device Market
• Transcatheter Embolization Device Market

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “bottom up” approach, which includes primary and secondary research methods.

Spanning over 356 pages, “U.S. Market for Peripheral Vascular Devices and Accessories” report provides information on Research Methodology, U.S. Peripheral Vascular Device Market Overview, Peripheral Vascular Stent Market, Pta Balloon Catheter Market, Atherectomy Device Market, Chronic Total Occlusion Device Market, Embolic Protection Device Market, Stent Graft Market, Surgical Graft Market, Arteriovenous (Av) Access Thrombectomy Device Market, Inferior Vena Cava Filter Market, Diagnostic And Interventional Catheter Market, Diagnostic And Interventional Guidewire Market, Introducer Sheath Market, Vascular Closure Device Market, Transcatheter Embolization Device Market, Abbreviations. In This report cover 38 Companies- C. R. Bard, Cordis, Abbott Laboratories, Terumo, Cook Medical, W. L. Gore, Boston Scientific, Covidien, Medtronic, St. Jude Medical, Cardiovascular Systems Inc, Atrium Medical, Endologix, Spectranetics,Pfizer, Argon Medical, AccessClosure, ALN International Inc., AngioDynamics, AngioScore etc.

For more information visit : http://www.marketresearchreports.com/idata-research/us-market-peripheral-vascular-devices-and-accessories

Find all Medical Devices Reports under a single page.

Alzheimer’s Pipeline Drugs Review, Alzheimer’s Disease Drug Market & Forecast - Global Analysis, New Report Launched

Alzheimer’s disease drug market is on the curvature stage. Since 2003, there is not any single “magic bullet” launched in the market to prevent or cure it. However, all current marketed products are going to be generic in the next 3-4 years. There are high unmet medical needs. The current unmet needs represent a huge opportunity for pharmaceutical companies which are developing targeted novel therapies. If successful, they will be in a position to command premium prices and tap the existing opportunity. Lot of drugs has failed in Phase III stage thus putting a greater impact on Alzheimer’s disease drug market.

From the year 2009 Alzheimer’s disease drug market is declining and it is expected to fall till 2016. But with the expected launch of some Alzheimer’s drugs from the year 2017 onwards, Alzheimer’s disease drug market is expected to revive in the coming years. However due to absence of exact potential drugs there will always remain a huge Unmet Alzheimer’s Drug Market. For the year 2018 Alzheimer’s Disease Drug Market will be just 10% of Unmet Alzheimer’s Disease Drug Market.

New research study titled “Alzheimer’s Pipeline Drugs Review, Alzheimer’s Disease Drug Market & Forecast - Global Analysis” provides a comprehensive assessment of the fast-evolving, high-growth Global Alzheimer’s Disease Market. This 110 page report with 29 Figures and 11 Tables studies the Global Alzheimer’s Disease Drug Market.

Present & Pipeline Drugs Studied in this Report-

1. Namenda

2. Ebixa

3. Axura

4. Aricept

5. Nootropil

6. Exelon

7. Memary

8. Solanezumab

9. LuAe58054

This report contains 10 chapters.

(Chapter 1): Executive Summary

(Chapter 2): This Chapter is divided into 2 parts

A. Alzheimer’s Disease Drug Market & Forecast data available from 2003 to 2018

B. Unmet Alzheimer’s Disease Drug Market & Forecast (Market Potential) data available from 2010 to 2018. (Unmet market is the potential market which could have been achieved if right drug have been introduced in the market)

(Chapter 3): This chapter talks about drugs which has failed while in Clinical trials

(Chapter 4): This chapter provides Market Share of Alzheimer’s Disease Drug from 2003 to 2018. All the 9 Alzheimer’s drug mentioned above have been covered in this chapter.

(Chapter 5): This chapter talks about Alzheimer’s Drugs performance. All important drugs mentioned above past, present & future market data available from 2003 to 2018.

(Chapter 6): Pipeline drugs (Solanezumab, LuAE58054, Gantenerumab, Crenezumab, TRx0237 (LMTX), MK-8931, ABT-126, AZD-1446) have been analyzed in this chapter. All drugs have been analyzed from 5 view points:

A. Clinical Development Stage

B. Pipeline Drug Sales Performance

C. Recent Clinical Development

D. Different Companies Deal

E. Investment

(Chapter 7): This chapter speaks of Alzheimer’s Drugs Company deals in four areas

A. Strategic Alliances in Alzheimer’s Disease Drug Market

B. Licensing Agreement in Alzheimer’s Disease Drug Market

C. Collaboration Deal in Alzheimer’s Disease Drug Market

D. Merger & Acquisition in Alzheimer’s Disease Drug Market

(Chapter 8): This chapter studies Funding in Alzheimer’s Disease Drugs Research. We have covered 5 institutes which provides fund for the research.

A. National Institute of Health

B. Alzheimer's Association

C. Cure Alzheimer’s Fund

D. Alzheimer’s Drug Discovery Foundation

E. BrightFocus Foundation [formerly American Health Assistance Foundation (AHAF)]

(Chapter 9): This chapter studies Growth Factors Driving the Alzheimer’s Disease Drug Market.

(Chapter 10): This chapter studies Challenges/Hindrances faced by Alzheimer’s Disease Drug Market.

Data Sources

• This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Research team of industry experts.
• Primary sources include industry surveys and telephone interviews with industry experts.
• Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

In addition to covering the Worldwide - Alzheimer’s Disease Drug Market Analysis, Failed Alzheimer’s Drugs, Worldwide - Alzheimer’s Disease Drug Market Share & Forecast, Worldwide – Alzheimer’s Drug Brands Market Performance, Pipeline Drugs Analysis in Alzheimer’s Disease Market, M&A, Licensing Agreement, Strategic Alliances & Collaboration Deals in Alzheimer’s Disease Drug Market, Funding in Alzheimer’s Disease Drugs Research, Key Drivers of Growth in Global Alzheimer’s Disease Drug Market, Key Challenges in the Global Alzheimer’s Disease Drug Market.

For more information visit : http://www.marketresearchreports.com/renub-research/alzheimer%E2%80%99s-pipeline-drugs-review-alzheimer%E2%80%99s-disease-drug-market-forecast-%E2%80%93-global

For other reports in Drug Discovery segment please visit: http://www.marketresearchreports.com/drug-discovery